GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity

Oral Oncology

Volumn 50, Issue 5, 2014, Pages 478-484

  Lin, Mei Chun ^a,b   Huang, Miao Juei ^b,c   Liu, Chiung Hui ^b   Yang, Tsung Lin ^a,c   Huang, Min Chuan ^b,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Epidermal growth factor receptor (EGFR); Glycosylation; Glycosyltransferase; Invasion; N acetylgalactosaminyltransferase 2 (GALNT2); Oral squamous cell carcinoma (OSCC)

Indexed keywords

AGGLUTININ; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MATRIGEL; N ACETYLGALACTOSAMINYLTRANSFERASE; N ACETYLGALACTOSAMINYLTRANSFERASE 2; PROTEIN KINASE B; UNCLASSIFIED DRUG; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; PRIMER DNA; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CARCINOMA CELL; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; ENZYME PHOSPHORYLATION; FETAL BOVINE SERUM; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MATRIGEL INVASION ASSAY; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SERUM; TISSUE MICROARRAY; TRANSWELL MIGRATION ASSAY; TUMOR INVASION; VICIA VILLOSA AGGLUTININ PULLDOWN ASSAY; WESTERN BLOTTING; GENETICS; GLYCOSYLATION; METABOLISM; METASTASIS; MOUTH TUMOR; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA PRIMERS; GLYCOSYLATION; HUMANS; MOUTH NEOPLASMS; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING;

EID: 84899065377     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.02.003     Document Type: Article

References (38)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2 2011 69 90
2. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 1 2013 11 30
3. S.M. Lippman, J. Sudbo, and W.K. Hong Oral cancer prevention and the evolution of molecular-targeted drug development J Clin Oncol 23 2 2005 346 356
4. M.A. Hollingsworth, and B.J. Swanson Mucins in cancer: protection and control of the cell surface Nat Rev Cancer 4 1 2004 45 60
5. D.W. Kufe Mucins in cancer: function, prognosis and therapy Nat Rev Cancer 9 12 2009 874 885
6. M.M. Fuster, and J.D. Esko The sweet and sour of cancer: glycans as novel therapeutic targets Nat Rev Cancer 5 7 2005 526 542
7. S. Hakomori Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines Adv Exp Med Biol 491 2001 369 402
8. K.G. Ten Hagen, T.A. Fritz, and L.A. Tabak All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases Glycobiology 13 1 2003 1R 16R
9. P.H. Jensen, D. Kolarich, and N.H. Packer Mucin-type O-glycosylation- putting the pieces together FEBS J 277 1 2010 81 94
10. G. Ragupathi Carbohydrate antigens as targets for active specific immunotherapy Cancer Immun Immunother 43 3 1996 152 157
11. Y.M. Wu, C.H. Liu, and R.H. Hu et al. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor Cancer Res 71 23 2011 7270 7279
12. D.J. Gill, K.M. Tham, and J. Chia et al. Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness Proc Natl Acad Sci USA 110 34 2013 E3152 3161
13. J.H. Park, T. Nishidate, and K. Kijima et al. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis Cancer Res 70 7 2010 2759 2769
14. Y. Matsumoto, Q. Zhang, and K. Akita et al. Pp-GalNAc-T13 induces high metastatic potential of murine Lewis lung cancer by generating trimeric Tn antigen Biochem Biophys Res Commun 419 1 2012 7 13
15. U. Mandel, H. Hassan, and M.H. Therkildsen et al. Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family Glycobiology 9 1 1999 43 52
16. M. Yokota, N. Ito, K. Hatake, K. Yane, H. Miyahara, and T. Matsunaga Aberrant glycosylation based on the neo-expression of poly-N-acetyllactosamine structures in squamous cell carcinomas of the head and neck Histochem J 29 7 1997 555 562
17. S. Kalyankrishna, and J.R. Grandis Epidermal growth factor receptor biology in head and neck cancer J Clin Oncol 24 17 2006 2666 2672
18. D.H. Dube, and C.R. Bertozzi Glycans in cancer and inflammation-potential for therapeutics and diagnostics Nat Rev Drug Discov 4 6 2005 477 488
19. S.H. Itzkowitz, E.J. Bloom, W.A. Kokal, G. Modin, S. Hakomori, and Y.S. Kim Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients Cancer 66 9 1990 1960 1966
20. E. Laack, H. Nikbakht, and A. Peters et al. Lectin histochemistry of resected adenocarcinoma of the lung: helix pomatia agglutinin binding is an independent prognostic factor Am J Pathol 160 3 2002 1001 1008
21. A. Konno, Y. Hoshino, S. Terashima, R. Motoki, and T. Kawaguchi Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis Clin Exp Metastasis 19 1 2002 61 70
22. D. Kademani, R.B. Bell, and S. Bagheri et al. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade J Oral Maxillofac Surg 63 11 2005 1599 1605
23. Y. Okada, I. Mataga, M. Katagiri, and K. Ishii An analysis of cervical lymph nodes metastasis in oral squamous cell carcinoma. Relationship between grade of histopathological malignancy and lymph nodes metastasis Int J Oral Maxillofac Surg 32 3 2003 284 288
24. T.L. Yang, C.P. Wang, J.Y. Ko, C.F. Lin, and P.J. Lou Association of tumor satellite distance with prognosis and contralateral neck recurrence of tongue squamous cell carcinoma Head Neck 30 5 2008 631 638
25. N. Mohtasham, S. Babakoohi, and A. Shiva et al. Immunohistochemical study of p53, Ki-67, MMP-2 and MMP-9 expression at invasive front of squamous cell and verrucous carcinoma in oral cavity Pathol Res Pract 209 2 2013 110 114
26. G. Rabinowits, and R.I. Haddad Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literature Oral Oncol 48 11 2012 1085 1089
27. W.C. Liao, C.H. Chen, and C.H. Liu et al. Expression of GALNT2 in human extravillous trophoblasts and its suppressive role in trophoblast invasion Placenta 33 12 2012 1005 1011
28. K.T. Schjoldager, S.Y. Vakhrushev, and Y. Kong et al. Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells Proc Natl Acad Sci USA 109 25 2012 9893 9898
29. C. Steentoft, S.Y. Vakhrushev, and H.J. Joshi et al. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology EMBO J 32 10 2013 1478 1488
30. J. Rubin Grandis, M.F. Melhem, and W.E. Gooding et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival J Natl Cancer Inst 90 11 1998 824 832
31. S. Wheeler, D.R. Siwak, and R. Chai et al. Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma Clin Cancer Res 18 8 2012 2278 2289
32. D. Soulieres, N.N. Senzer, E.E. Vokes, M. Hidalgo, S.S. Agarwala, and L.L. Siu Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck J Clin Oncol 22 1 2004 77 85
33. E.E. Cohen, F. Rosen, and W.M. Stadler et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck J Clin Oncol 21 10 2003 1980 1987
34. W. Shaib, S. Kono, and N. Saba Antiepidermal growth factor receptor therapy in squamous cell carcinoma of the head and neck J Oncol 2012 2012 521215
35. E.E. Cohen Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck J Clin Oncol 24 17 2006 2659 2665
36. D.L. Wheeler, S. Huang, and T.J. Kruser et al. Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members Oncogene 27 28 2008 3944 3956
37. K. Matsumoto, H. Yokote, and T. Arao et al. N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor Cancer Sci 99 8 2008 1611 1617
38. J.J. Park, J.Y. Yi, and Y.B. Jin et al. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells Biochem Pharmacol 83 7 2012 849 857